FC
CNS Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TPI-287 (Abeotaxane) | Recurrent Glioblastoma, Neuroblastoma, Medulloblastoma, Refractory Prostate Cancer, Tauopathy Disease (Dementia) | Phase 2 |
| Berubicin | Glioblastoma | Phase 2/3 |
Leadership Team at CNS Pharmaceuticals
RL
Rami Levin
President & Chief Executive Officer
SO
Steve O'Loughlin
Chief Financial Officer
LK
Lynne Kelley
Chief Medical Officer
EF
Eric Faulkner
Chief Technology Officer
DW
Dylan Wenke
Chief Business Officer
JR
Jeffry R. Keyes
Director
BM
Bettina M. Cockroft
Director
AM
Amy Mahery
Director
J(
Jerzy (George) Gumulka
Director